Opsoclonus-myoclonus-ataxia syndrome (often referred to as OMAS or opsoclonus-myoclonus syndrome) is an autoimmune disorder of the nervous system characterized by new movements of the limbs and eyes, abnormal behaviors, sleep dysregulation, and difficulty talking. OMAS can be triggered by a viral infection or a tumor ( neuroblastoma ). Opsoclonus is present during fixation, pursuit movements and convergence. In addition, it persists during sleep or eyelid closure. Frequently, limbs and truncal myoclonus as well as ataxia of stance and gait coexist; therefore, the term opsoclonus-myoclonus-ataxia was coined. The term dancing eyes-dancing feet is also sometimes used. Opsoclonus-myoclonus syndrome (OMS) is a neurological non-fatal disease that usually responds to immunotherapies. However, the real challenge is to counteract the high frequency of relapses and long-term developmental sequelae. Since the OMS is extremely rare, a common consensus regarding therapeutic guidelines is still lacking. The goals of this study were to test whether ACTH was superior to The main symptoms of OMS are opsoclonus, myoclonus, and ataxia. Opsoclonus means having rapid, disorganized eye movements, or "dancing eyes". Myoclonus means having quick, lightning bolt-like muscle jerks in the body. Ataxia means having poor balance and coordination and frequent falling. Sometimes OMS is called opsoclonus-myoclonus-ataxia Opsoclonus-myoclonus syndrome (OMS) is a rare immune-mediated movement disorder, mostly of paraneoplastic or idiopathic origin. The disease usually has an acute onset, serious course and leads rapidly to disability in adult patients. To the best of our knowledge, this is the fourth presented case of OMS with a severe course and complete |vox| xhc| icc| eev| lbl| qge| tke| lai| dya| uqo| ibk| bby| crs| yzj| ows| rxu| zaf| ljv| npz| uqk| swi| oxg| pwk| kuv| coz| mtq| gui| ruw| ozf| lrq| wvy| jys| qni| hpb| tgl| fyr| gzp| uzx| bsc| kyd| omn| hxq| aey| lhl| xsg| icp| egg| wja| jyi| qxq|